v3.26.1
Share-Based Compensation - Summary of Outstanding Activity of Options, Restricted Stock and Restricted Stock Units under MRI EICP (Detail) - MRI EICP [Member] - $ / shares
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Restricted Shares [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Beginning of period 0 626,108
Number of Shares, Granted 0 0
Number of Shares, Vested 0 (570,797)
Number of Shares, Forfeited   0
Number of Shares, End of period 0 55,311
Weighted Average Grant Date Fair Value, Beginning of period $ 0 $ 11.93
Weighted Average Grant Date Fair Value, Granted 0 0
Weighted Average Grant Date Fair Value, Vested 0 11.98
Weighted Average Grant Date Fair Value, Forfeited   0
Weighted Average Grant Date Fair Value, End of period $ 0 $ 11.38
Restricted Stock Units [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Beginning of period 130,000 170,000
Number of Shares, Granted 1,281,989 0
Number of Shares, Vested 0 0
Number of Shares, Forfeited   0
Number of Shares, End of period 1,411,989 170,000
Weighted Average Grant Date Fair Value, Beginning of period $ 4.97 $ 7.63
Weighted Average Grant Date Fair Value, Granted 1.53 0
Weighted Average Grant Date Fair Value, Vested 0 0
Weighted Average Grant Date Fair Value, Forfeited   0
Weighted Average Grant Date Fair Value, End of period $ 1.85 $ 7.63
Options [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Shares, Beginning of period 2,100,000 2,325,000
Number of Shares, Granted 0 0
Number of Shares, Vested (700,000) 0
Number of Shares, Forfeited   0
Number of Shares, End of period 1,400,000 2,325,000
Weighted Average Grant Date Fair Value, Beginning of period $ 6.77 $ 7.04
Weighted Average Grant Date Fair Value, Granted 0 0
Weighted Average Grant Date Fair Value, Vested 6.77 0
Weighted Average Grant Date Fair Value, End of period $ 6.77 $ 7.04